[BMY] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[BMY] Bristol-Myers Squibb Company
Announcement Date
14-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- -9.54%
Quarter Report
BMY's Result
BMY's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 45,006,000 46,159,000 46,385,000 42,518,000 26,145,000 22,561,000 20,776,000 13.74%
PBT 8,440,000 7,713,000 8,098,000 -6,871,000 4,975,000 6,010,000 5,131,000 8.64%
Tax 400,000 1,368,000 1,084,000 2,124,000 1,515,000 1,031,000 4,156,000 -32.29%
NP 8,025,000 6,327,000 6,994,000 -8,995,000 3,439,000 4,952,000 1,007,000 41.30%
Tax Rate -4.74% -17.74% -13.39% - -30.45% -17.15% -81.00% -
Total Cost 36,981,000 39,832,000 39,391,000 51,513,000 22,706,000 17,609,000 19,769,000 10.99%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 17.83 13.71 15.08 -21.16 13.15 21.95 4.85 24.22%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 3.88 2.97 3.15 -3.98 2.02 3.03 0.61 36.09%
EPS Diluted 3.86 2.95 3.12 -3.98 2.01 3.03 0.61 35.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.